Endometriosis associated with hyperprolactinaemia
This study investigated serum prolactin levels in endometriosis patients and other pelvic lesions to determine prolactin's role in endometriosis development and progression.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
The paper reports serum prolactin (PRL) levels in patients with endometriosis and in patients with other pelvic lesions to evaluate whether PRL is involved in the development and progression of endometriosis. It also presents evidence that treatment with bromocriptine alone or combined with danazol may be effective for endometriosis. The key limitations explicitly or implicitly noted from the provided text are that the report is primarily associative/observational regarding PRL levels rather than a detailed mechanistic demonstration of causality, and the available information does not specify study design details or outcome metrics. This paper is centrally about endometriosis — it examines endometriosis-associated hyperprolactinaemia and reports potential effectiveness of bromocriptine (with or without danazol) in that context.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
References (6)
- A proposed classification of pelvic endometriosis. via openalex
- Mechanisms of Development of Prolactin-Induced Adenomyosis in Mice via openalex
- The induction of adenomyosis in mice by intrauterine pituitary isografts via openalex
- W2032552530 via openalex
- W2410955081 via openalex
- W6714862897 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00